Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 12 June 2021
David Adams is Professor of Hepatology at the University of Birmingham and honorary consultant physician to the Liver and HPB Unit at Queen Elizabeth Hospital. His clinical interests are transplant hepatology and autoimmune liver disease.
Research interests are focused on laboratory-based studies into the mechanisms of immune-mediated liver disease and immune responses to liver cancer. This work is currently being translated into clinical studies to evaluate new therapies for liver disease.
After initial training in hepatology in Birmingham, David worked in the National Cancer Institute at the National Institutes of Health in Bethesda, USA.
James Ferguson qualified in 1998 and after completion of his general medical training joined the Scottish Liver Transplant Unit in 2002. His research leading to a thesis studied endothelial dysfunction in patients with portal hypertension.
His ongoing research interests include cardiovascular and renal dysfunction after liver transplantation and the complications of portal hypertension. His specialist interests include portal hypertension, vascular disorders of the liver, alcoholic liver disease and adolescent transition.
Surgeon Commander Dennis Freshwater graduated from University College London in 1992, and is a Royal Navy Medical Officer. He became a Member of the Royal College of Physicians (UK) in 1999 and his Specialist Registrar training was carried out in the West Midlands. He was appointed as a Consultant Hepatologist at the Queen Elizabeth Hospital in February 2007, and is the lead for ERCP services.
Postgraduate qualifications include a MD in 2007 for his doctoral thesis on the evolution of hepatitis B and C in liver transplant recipients undergoing antiviral therapy. Current clinical interests include chronic viral hepatitis as well as therapeutic ERCP. He is also a Principal Investigator for several clinical trials in Hepatitis B and C.
Geoffrey Haydon qualified from Edinburgh University and, after completing his basic medical training, worked in the Scottish Liver Transplant Unit in Edinburgh from its inception in 1992.
While in Edinburgh, Geoffrey completed his thesis under the guidance of Professor Peter Hayes; this examined some clinical issues of the molecular virology of chronic hepatitis C infection.
In 2000 he moved to Birmingham, taking a post as a Clinical Lecturer at the University of Birmingham. He now works as an NHS Consultant within the Liver Unit at the Queen Elizabeth Hospital.
His specialist interests within the unit include chronic hepatitis B and C infection and various aspects of liver transplantation.
He was appointed Consultant Physician and Transplant Hepatologist to the liver unit in 2008. Whilst Andrew has particular responsibilities for the Hepatitis C and B clinics, he welcomes general and transplant-related referrals, especially those relating to complex biliary disease and ERCP.
Stefan Hübscher is a consultant histopathologist and a Professor of Hepatic Pathology at the University of Birmingham. His interests include the pathology (the study of diseases and their causes) of the liver and liver transplantation, organ rejection and recurrence of liver diseases following a transplant. He is also interested in the pathology of hepatic, biliary and pancreatic cancers and the make up of the hepatitis C virus infection.
His published works include more than 150 papers in peer-reviewed journals, 32 invited review articles and 19 book chapters.
Philip, a graduate of the University of Manchester, completed his training at a number of postgraduate centres in London, including Guy's Hospital, Queen's Square and the Royal Marsden.
In 1980 he was appointed Senior Lecturer and Assistant Director at The Institute of Liver Studies, in charge of the newly built Sheikh Zaid Centre at Kings College Hospital in London.
In 1992 he undertook the positions of Professor of Clinical Oncology at the Chinese University of Hong Kong and Director of the Sir Y.K. Pao Centre for Cancer. He went on to establish a large clinical trials unit.
In 2002 Philip returned to the UK to join the Institute for Cancer Studies at the University of Birmingham with a remit to apply laboratory research to real life setting.
Currently he is director of the Cancer Research UK Clinical Trials Unit, one of the largest of its type in the country, and has published over 400 articles, including 50 textbook chapters and 50 reviews.
Brin Mahon qualified from Guy's and St. Thomas' Hospitals in 1995 and continued his junior medical career in and around London until moving to Cardiff in September 1999 to start specialist training in Radiology at the University Hospital of Wales. In the final years of this, he undertook further sub-speciality training in hepato-biliary radiology, and gastrointestinal and endoscopic ultrasound in one of the best training schemes for endoscopic ultrasound in the UK.
In 2004 Brin joined UHB, where he established and leads the Endoscopic Ultrasound Unit (EUS) in one of the biggest EUS units in the UK, as well as specialising in hepato-biliary and gastrointestinal imaging.
Kamarjit Mangat completed radiology training in the West Midlands in 2004, including a year as interventional radiology fellow with a bias to hepato-biliary intervention. He also spent time at St. James Hospital, Leeds, learning specialist liver MRI techniques.
He did a three-month sabbatical at the University of California, San Diego, to gain further experience in MRI, intervention and to develop knowledge of imaging guided radiofrequency ablation of liver tumours. This service is now offered at University Hospital Birmingham.
David Mayer trained at Guy's Hospital and obtained his Fellowship of the Royal College of Surgeons in London in 1980. He developed an interest in gallstones and pancreatic disease and became a Master of Surgery in 1986.
He joined the Birmingham Liver Unit as a Senior Registrar in 1986 and was trained as a hepato-biliary and liver transplant surgeon in Birmingham and subsequently as a Fellow at the University of California.
In 1990 he was appointed as Consultant Surgeon to the Liver Units at the Queen Elizabeth Hospital and the Children Hospital in Birmingham, specialising in liver, biliary and pancreatic surgery and in liver and intestinal transplantation. He is currently Chairman of the Liver Advisory Group to UK Transplant.
After specialist training in Vienna and Birmingham, Darius Mirza was appointed Consultant Hepato-biliary and Transplant Surgeon in 1996. He is attached to the Liver Units at the Queen Elizabeth and the Birmingham Childrens Hospital. His clinical interests are in the surgical management of liver, pancreatic and biliary disease, with a special interest in primary and secondary liver cancer, pancreatic cancer, and adult and paediatric liver transplantation.
Darius's research interests lie in the areas of "marginal" donors, technical innovations (split livers, transplantation for intestinal failure), bile duct strictures and metastatic liver cancer. He is a member of several national and international committees and till recently was Secretary of the European Liver and Intestinal Transplant Association.
David Mutimer is a consultant hepatologist and is clinical service lead for liver medicine. He trained in Melbourne, Newcastle and then Birmingham. He has worked in the Birmingham Queen Elizabeth Hospital Liver Unit since 1989.
His main clinical interests include liver transplantation and viral hepatitis. He has established a number of clinics that specialise in the management of patients with chronic viral hepatitis B and C infection. In addition, his clinical research includes participation in trials of new antiviral drugs for patients with viral hepatitis.
James Neuberger qualified from Oxford University after undertaking various posts in general medicine and gastroenterology. From 1979 he worked in the Liver Unit at Kings College Hospital with Professor Roger Williams CBE, Director of the Institute of Hepatology and was involved with the early transplant programme in Cambridge. He moved to Birmingham in 1987 to work at the Queen Elizabeth Hospital.
His special interests include primary biliary cirrhosis and other autoimmune diseases, drug and alcohol related liver disease, and aspects of liver transplantation. He is currently the editor of 'Transplantation' and formerly held the position of associate editor of the 'Journal of Hepatology' and 'Liver International'. He was president of the British Association for the Study of the Liver from 2005 to September 2007.
Phil Newsome is a Senior Lecturer and Consultant Hepatologist involved in general and transplant hepatology. He has a specific interest in metabolic liver diseases such as fatty liver disease and conditions such as porphyria, glycogen storage disorders, tyrosinaemia and cystic fibrosis. He is actively recruiting patients with fatty liver disease for trials of new drugs.
He is also the Clinical Director of the Birmingham University Stem Cell Centre and is currently running clinical trials of stem cells in patients with chronic liver disease.
Simon Olliff is a Consultant Radiologist and has been working with the Liver Unit since November 1989. Simon has significant experience in all types of liver, hepato-biliary and liver transplant imaging and interventional radiology procedures. He is also a lecturer and demonstrator at many UK and overseas scientific conferences and teaching courses.
Dr Palmer is a Cancer Research UK Clinician Scientist and Honorary Consultant in Medical Oncology
He graduated in medicine from the University of Birmingham in 1995. After general medical training leading to MRCP (UK) he began specialist training in medical oncology. He was awarded a Medical Research Council fellowship to undertake research into cancer gene therapy leading to his PhD, and won the Association of Cancer Physicians McElwain Scholarship, funding a sabbatical at the Chinese University of Hong Kong.
In 2005, Dr Palmer took up his current position of Cancer Research UK Clinician Scientist and Consultant in Medical Oncology, maintaining his research interest in immuno-gene therapy. His clinical interest is in hepato pancreato biliary and colorectal malignancy. He is also building a portfolio of early phase clinical trials and translational studies, as well as making significant contributions to national phase III trials.
Dr Tanière graduated in Histopathology from the University of Lyon, France, in 1995. He then did a PhD in the Unit of Molecular Carcinogenesis at the International Agency for Research on Cancer, Lyon (graduated in 2002), working on the research project "Molecular mechanisms of carcinogenesis in upper gastrointestinal carcinomas, implication of TP53 gene".
From September 2000 to October 2002, he held the position of "Maitre de Conferences des Universites-Praticien Hospitalier" at the University Hospital E. Herriot, Lyon (Joint appointment: University of Lyon and E. Herriot University Hospital) with a special interest in gastrointestinal, pancreato-biliary and urological pathology.
Since October 2002, Philippe has been a Consultant in Histopathology at University Hospital Birmingham NHS Foundation Trust and Honorary Senior Lecturer at the Medical School, Birmingham with a special interest in upper/lower gastrointestinal pathology, pancreato-biliary pathology and molecular pathology.
Dhiraj Tripathi is a consultant hepatologist, with duties covering both general and transplant hepatology. He trained in Edinburgh and took up his current post in 2008. He has particular interest in clinical aspects of portal hypertension, and has completed a higher degree based on his clinical research in Edinburgh.
He welcomes referrals of patients with complications of portal hypertension. He also has an interest in non-cirrhotic portal hypertension. He has extensive experience in the management of patients with varices, and runs a specialised endoscopy list.
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
See why our hospitals are great places to work.